Brand name: Aubagio.
Generic name: Teriflunomide.
Who takes it?:
This is for adults with Active Relapsing Remitting MS, who have had 2 relapses in 2 years.
It is considered to be a first line treatment.
Studies show that is reduces relapses by 30%.
Aubagio should not be taken in pregnancy.
Women of childbearing age should use contraception during treatment and for 2 years after. Men should also use a barrier method of contraception during treatment and for 2 years after.
How is it given?:
Aubagio is an oral tablet taken once a day.
Who Monitors it?:
Bloods are obtained once a month for six months then every 3 months. You will be informed when they are due, we will ask you either to attend your Gp practice or the MS Nurse home phlebotomy service will collect them.
The MS Nurse phlebotomy service, can come to your home environment or after negotiation with your employer, at your work place.
At each MS Nurse appointment you will be asked about your Aubagio:
- If you have missed any tablets.
- Have any side effects.
- Had any infections.
Side effects:
- Hair thinning in the first three months.
- Nausea.
- Diarrhoea
- Raised liver enzymes.
- Rash.
- Decreased platelets.
Travel:
This medication does not need to be kept in your hand luggage when travelling abroad, however we suggest you do, due to main luggage occasionally being lost or delayed.
Vaccines:
https://www.mssociety.org.uk/care-and-support/health-and-social-care/health-care/flu-jabs
Support:
https://mstrust.org.uk/a-z/aubagio-teriflunomide